GSK-690693

DB12745InvestigationalSmall molecule

GSK690693 has been used in trials studying the treatment of Tumor, CANCER, and Lymphoma.

Mechanism: Pharmacologically active on Protein kinase C and cAMP-dependent protein kinase (Protein kinase A)
Curator reviewed
Formula / weight: C₂₁H₂₇N₇O₃ · 425.4842 g/mol (avg)
Code names: GSK 690693

Resolves to

Compound

Structure

InChIKeyKGPGFQWBCSZGEL-ZDUSSCGKSA-NSMILES[H][C@]1(COC2=C3N(CC)C(=NC3=C(N=C2)C#CC(C)(C)O)C2=NON=C2N)CCCNC1

Targets

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with GSK-690693, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.